Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
2.
Hayempour BJ, Alavi A. Retraction Note: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging. Eur J Nucl Med Mol Imaging. 2013. doi:10.​1007/​s00259-013-2613-6.
Metadata
Title
Author’s comment on the retraction of “Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging”
Author
Abass Alavi
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2646-x

Other articles of this Issue 2/2014

European Journal of Nuclear Medicine and Molecular Imaging 2/2014 Go to the issue

Original Article

High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT

Book Review

Ayfer Haydaroglu, Gokhan Ozygit (eds): Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer

Review Article

Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations

Erratum

Erratum to: Twins in spirit: DOTATATE and high-affinity DOTATATE

Erratum

Erratum to: Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma

Original Article

131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study